500 medicines being developed for neurological conditions

_Trendwatch
100 million people in the United States, or nearly a third of people in the United States, suffer from a neurological condition of which multiple sclerosis is one. Alzheimers, Parkinsons, dementia, ALS, brain tumors and conditions, traumatic brain injuries, migraine headaches, MS, chronic pain, stroke damage, genetic disorders, and epilepsy are among the thousand neurological conditions counted.

Over 500 new medications are in pharmaceutical companies drug development pipelines to treat neurological problems. Over seventy percent represent a brand new or “first in class” treatment approach.

In multiple sclerosis, the new candidate focuses on myelin repair. Myelin covers nerve fibers and is like insulation that allows the nerve signal to travel faster without interruption. It would help new myelin to grow to repair damaged nerve fibers.

There is nothing like this now, as the major MS medications are focused on preventing the immune system from mistakenly attacking the myelin protective sheath over the nerve fibers. These misguided attacks on the nerve fibers and brain neurons are why MS is considered to be an autoimmune disease.

Many of the alternative, spiritual, exercise, and healthy living approaches described in my book could help many people battling with chronic disease. See
https://www.amazon.com/Multiple-Sclerosis-Mission-Remission-Healing-ebook/dp/B07D7JBZ5L/ref=mp_s_a_1_2?ie=UTF8&qid=1529367853&sr=8-2&pi=AC_SX236_SY340_FMwebp_QL65&keywords=multiple+sclerosis+Mission+remission

Advertisements